Warning: The NCBI web site requires JavaScript to function. more...
Designing an experimental HIV/HCV intervention to promote the safe re-use of drug preparation materials by injection drug users in Puerto Rico.
Finlinson HA, Colón HM, Negrón J, Robles RR.
Harm Reduct J. 2008 Apr 28;5:14.
Related citations
Pilot trial of an intervention aimed at modifying drug preparation practices among injection drug users in Puerto Rico.
Colon HM, Finlinson HA, Negron J, Sosa I, Rios-Olivares E, Robles RR.
AIDS Behav. 2009 Jun;13(3):523-31. Epub 2009 Mar 24.
Detection of HIV-1 DNA in needle/syringes, paraphernalia, and washes from shooting galleries in Miami: a preliminary laboratory report.
Shah SM, Shapshak P, Rivers JE, Stewart RV, Weatherby NL, Xin KQ, Page JB, Chitwood DD, Mash DC, Vlahov D, McCoy CB.
J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Mar 1;11(3):301-6.
Parenteral transmission of HIV among injection drug users: assessing the frequency of multiperson use of needles, syringes, cookers, cotton, and water.
McCoy CB, Metsch LR, Chitwood DD, Shapshak P, Comerford ST.
J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S25-9.
A longitudinal study of syringe acquisition by Puerto Rican injection drug users in New York and Puerto Rico: implications for syringe exchange and distribution programs.
Finlinson HA, Oliver-Vélez D, Deren S, Cant JG, Colón HM, Robles RR, Kang SY, Andía JF.
Subst Use Misuse. 2006;41(9):1313-36.
Impact of pharmacy-based syringe access on injection practices among injecting drug users in Minnesota, 1998 to 1999.
Cotten-Oldenburg NU, Carr P, DeBoer JM, Collison EK, Novotny G.
J Acquir Immune Defic Syndr. 2001 Jun 1;27(2):183-92.
Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: implications for HIV and hepatitis C prevention.
Morissette C, Cox J, De P, Tremblay C, Roy E, Allard R, Stephenson R, Graves L.
Int J Drug Policy. 2007 May;18(3):204-12. Epub 2006 Oct 2.
Risk behaviors, HIV seropositivity, and tuberculosis infection in injecting drug users who operate shooting galleries in Puerto Rico.
Robles RR, Marrero CA, Reyes JC, Colón HM, Matos TD, Finlinson HA, Muñoz A, Meléndez M, Sahai H.
J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Apr 15;17(5):477-83.
Injecting shared drugs: an observational study of the process of drug acquisition, preparation, and injection by Puerto Rican drug users.
Finlinson HA, Colón HM, López MS, Robles RR, Cant JG.
J Psychoactive Drugs. 2005 Mar;37(1):37-49.
"Vivo para consumirla y la consumo para vivir" ["I live to inject and inject to live"]: high-risk injection behaviors in Tijuana, Mexico.
Strathdee SA, Fraga WD, Case P, Firestone M, Brouwer KC, Perez SG, Magis C, Fraga MA.
J Urban Health. 2005 Sep;82(3 Suppl 4):iv58-73.
Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.
Neaigus A, Zhao M, Gyarmathy VA, Cisek L, Friedman SR, Baxter RC.
J Urban Health. 2008 May;85(3):309-22. Epub 2008 Mar 14.
Drug choice, spatial distribution, HIV risk, and HIV prevalence among injection drug users in St. Petersburg, Russia.
Kruse GR, Barbour R, Heimer R, Shaboltas AV, Toussova OV, Hoffman IF, Kozlov AP.
Harm Reduct J. 2009 Jul 31;6:22.
A sterile syringe for every drug user injection: how many injections take place annually, and how might pharmacists contribute to syringe distribution?
Lurie P, Jones TS, Foley J.
J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S45-51.
New York City pharmacists' attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access.
Coffin PO, Linas BP, Factor SH, Vlahov D.
J Urban Health. 2000 Dec;77(4):781-93.
Reaching out beyond the hills: HIV prevention among injecting drug users in Manipur, India.
Hangzo C, Chatterjee A, Sarkar S, Zomi GT, Deb BC, Abdul-Quader AS.
Addiction. 1997 Jul;92(7):813-20.
Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
Birkhead GS, Klein SJ, Candelas AR, O'Connell DA, Rothman JR, Feldman IS, Tsui DS, Cotroneo RA, Flanigan CA.
Int J Drug Policy. 2007 Oct;18(5):417-25. Epub 2007 Feb 20. Review.
Meta-Analysis of Hepatitis C Seroconversion in Relation to Shared Syringes and Drug Preparation Equipment.
Pouget ER, Hagan H, Des Jarlais DC.
Addiction. 2011 Dec 13. doi: 10.1111/j.1360-0443.2011.03765.x. [Epub ahead of print]
Prevalence and correlates of indirect sharing practices among young adult injection drug users in five U.S. cities.
Thiede H, Hagan H, Campbell JV, Strathdee SA, Bailey SL, Hudson SM, Kapadia F, Garfein RS; DUIT Study Team.
Drug Alcohol Depend. 2007 Nov;91 Suppl 1:S39-47. Epub 2007 Apr 26.
Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia.
Maher L, Jalaludin B, Chant KG, Jayasuriya R, Sladden T, Kaldor JM, Sargent PL.
Addiction. 2006 Oct;101(10):1499-508.
Syringe and needle exchange as HIV/AIDS prevention for injection drug users in Puerto Rico.
Robles RR, Colón HM, Matos TD, Finlinson HA, Muñoz A, Marrero CA, García M, Reyes JC.
Health Policy. 1998 Sep;45(3):209-20.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on